Friday's announced financings: August 4

Here’s your roundup of Friday's announced equity financings, courtesy of PrivatePlacements.com, the only database that tracks every financing, every day.

1. Eupraxia Pharmaceuticals Inc. (TSX: EPRX)

• Gross Proceeds: $22 million
• Sector: Pharmaceuticals
• Units issued: 3.14 million
• Type: Common shares
• Price: $7.00
• Warrants: None
• Agents: Non-brokered 
• Use of Proceeds: Ongoing research

Company breakdown:

• Pharmaceutical company developing a product to address knee pain in osteoarthritis and eosinophilic esophagitis
• Recently reported "positive" data from its Phase 2b osteoarthritis trial

2. Renegade Gold Inc. (TSX-V: RAGE)

• Gross Proceeds: $5 million
• Sector: Precious metals
• Units issued: 9.43 million
• Type: Special units
• Price: $0.53
• Warrants: Full; $0.75; Two years
• Agents: Non-brokered
• Use of Proceeds: Not stated

Company breakdown:

• Precious metals junior focused on projects in the Red Lake mining district in Ontario
• Changed name from Trillium Gold in July
• Recently acquired Pacton Gold

3. BioNxt Solutions Inc. (CSE: BNXT)

• Gross Proceeds: $3.97 million
• Sector: Biotech
• Units issued: 15 million
• Type: Common shares
• Price: $0.265
• Warrants: None
• Agents: Non-brokered
• Use of Proceeds: Research and development

Company breakdown:

• Bioscience company working on drug formulation, point-of-care diagnostics, and psychedelics
• Recently signed a letter of intent to acquire 100% of intellectual property rights and to develop an oral dissolvable film drug reformulation

4. Megawatt Lithium and Battery Metals Corp. (CSE: MEGA)

• Gross Proceeds: $1.4 million
• Sector: Lithium
• Units issued: 8.75 million
• Type: Common shares
• Price: $0.16
• Warrants: None
• Agents: Non-brokered
• Use of Proceeds: Ongoing exploration

Company breakdown:

• Lithium and battery metals junior with projects in British Columbia
• Recently acquired the remaining 20% of numbered company that owns two silver-zinc projects in Australia